ArticleBMC cardiovascular disorders2026
Grisel's syndrome as an early manifestation of Kawasaki disease preceding Kawasaki disease shock syndrome: a case report.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundKawasaki disease shock syndrome (KDSS) is a severe and uncommon complication of Kawasaki disease (KD). Grisel's syndrome (GS), a rare non-traumatic atlantoaxial subluxation, has been seldom described in KD. To our knowledge, this is the first documented case in which GS was the initial manifestation of KD and preceded the development of KDSS. CASE PRESENTATION: A 4-year-old boy presented with fever, cervical lymphadenopathy, and restricted neck mobility. Cervical computed tomography revealed atlantoaxial subluxation. He was initially diagnosed with cervical lymphadenitis and treated with antibiotics, but his symptoms persisted and rapidly progressed to shock. He was subsequently diagnosed with GS and KDSS. Management with fluid resuscitation, intravenous immunoglobulin, corticosteroids, and aspirin stabilized his hemodynamic status and improved KD-related symptoms. With systemic inflammation controlled and cervical immobilization applied, GS subsequently resolved. At 6 months of follow-up, echocardiography showed no coronary artery abnormalities, and no recurrence of GS or neurological sequelae was observed.
conclusionsClinicians should recognize GS as a potential early manifestation of KD and maintain vigilance for progression to KDSS. Timely recognition and management could prevent severe cardiac and neurological complications in patients with KD complicated by GS and KDSS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.